X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (579) 579
Publication (67) 67
Book Chapter (7) 7
Book Review (6) 6
Book / eBook (2) 2
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (335) 335
humans (311) 311
gastroenterology & hepatology (251) 251
hepatitis b (240) 240
antiviral agents - therapeutic use (217) 217
hepatitis b, chronic - drug therapy (213) 213
hepatitis b virus (187) 187
chronic hepatitis b (185) 185
nucleoside analogs (168) 168
nucleoside analogues (163) 163
male (159) 159
hepatitis (158) 158
female (157) 157
lamivudine (150) 150
interferon (148) 148
entecavir (142) 142
adult (138) 138
middle aged (137) 137
treatment outcome (133) 133
therapy (111) 111
tenofovir (109) 109
antiviral therapy (108) 108
hepatocellular-carcinoma (102) 102
hepatitis b virus - genetics (101) 101
adefovir dipivoxil (96) 96
hepatocellular carcinoma (96) 96
guanine - analogs & derivatives (87) 87
hepatitis b, chronic - virology (87) 87
infectious diseases (84) 84
tenofovir disoproxil fumarate (83) 83
cirrhosis (82) 82
nucleoside analogue (81) 81
virology (81) 81
hepatitis b virus - drug effects (78) 78
antigens (72) 72
drug resistance (69) 69
antiviral agents (67) 67
dna, viral - blood (67) 67
hepatitis b e antigens - blood (66) 66
virus infection (66) 66
guanine - therapeutic use (63) 63
risk factors (63) 63
surface-antigen (63) 63
aged (61) 61
hepatitis b surface antigen (59) 59
hepatitis b surface antigens - blood (59) 59
liver (59) 59
natural-history (59) 59
deoxyribonucleic acid--dna (58) 58
mutation (57) 57
patients (57) 57
liver cancer (56) 56
viral load (56) 56
pharmacology & pharmacy (55) 55
risk (55) 55
antiviral agents - administration & dosage (54) 54
virus diseases (54) 54
care and treatment (53) 53
hbv (53) 53
nucleoside analog therapy (53) 53
adenine - analogs & derivatives (52) 52
health aspects (51) 51
management (50) 50
young adult (50) 50
hepatology (49) 49
hepatitis b e antigen (48) 48
chronic hepatitis-b (47) 47
digestive system diseases (47) 47
liver cirrhosis (47) 47
hepatitis b, chronic - complications (46) 46
recurrence (46) 46
time factors (45) 45
virological response (45) 45
antiviral agents - adverse effects (44) 44
retrospective studies (44) 44
infection (43) 43
nucleoside analog (43) 43
lamivudine - therapeutic use (42) 42
adefovir (41) 41
drug therapy, combination (41) 41
gastroenterology and hepatology (41) 41
genotype (41) 41
hepatitis b - drug therapy (41) 41
nucleosides - therapeutic use (41) 41
resistance (41) 41
drug resistance, viral (39) 39
hbsag (39) 39
medicine & public health (39) 39
peginterferon alpha-2a (39) 39
adenine - therapeutic use (38) 38
antiviral agents - pharmacology (38) 38
drug therapy (38) 38
pegylated interferon (38) 38
virus (38) 38
closed circular dna (37) 37
e-antigen seroconversion (37) 37
liver diseases (37) 37
organophosphonates - therapeutic use (37) 37
hepatitis b, chronic - diagnosis (36) 36
lamivudine therapy (35) 35
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (551) 551
Korean (19) 19
French (4) 4
German (4) 4
Russian (3) 3
Spanish (3) 3
Japanese (2) 2
Chinese (1) 1
Croatian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Hepatology, ISSN 0168-8278, 09/2018, Volume 69, Issue 3, pp. 584 - 593
Treatment with nucleos(t)ide analogues (NA) leads to hepatitis B virus (HBV) DNA suppression in most patients with chronic hepatitis B (CHB), but HBV surface... 
Discontinuation of treatment | Nucleos(t)ide analogue (NA) | Chronic hepatitis B | PD-L1 blockade | T cell phenotype | HBV-specific T cell response | VACCINATION | VIRAL CONTROL | DISCONTINUATION | PATHOGENESIS | PREVENT RELAPSE | LIVER-DAMAGE | INFECTION | DYSFUNCTION | GASTROENTEROLOGY & HEPATOLOGY | LONG-TERM TREATMENT | TENOFOVIR
Journal Article
Current Treatment Options in Infectious Diseases, ISSN 1523-3820, 9/2016, Volume 8, Issue 3, pp. 177 - 193
There are only two currently approved classes of hepatitis B virus (HBV) antiviral agents, pegylated interferon (Peg-IFN), and nucleos(t)ide analogs (NAs) for... 
Antiviral therapy | Medicine & Public Health | qHBsAg | Infectious Diseases | Peg-IFN | Hepatitis B virus | Nucleos(t)ide analog | Monitoring response | Viral Infections (J Tang, Section Editor)
Journal Article
Journal Article
Molecular and clinical oncology, ISSN 2049-9450, 07/2016, Volume 5, Issue 1, p. 3
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated mortalities, and its prevalence is expected to increase in future decades.... 
Journal Article
Gastroenterology, ISSN 0016-5085, 06/2018, Volume 154, Issue 8, pp. 2280 - 2281
Journal Article
Journal Article
by Xie, LQ and Liao, GC and Chen, HJ and Xia, MY and Huang, X and Fan, R and Peng, J and Zhang, XY and Liu, HY
BMC INFECTIOUS DISEASES, ISSN 1471-2334, 07/2019, Volume 19, Issue 1, pp. 640 - 9
Background: The virological or clinical relapse is common in chronic hepatitis B (CHB) patients after stopping long-term nucleos(t)ide analogue (NA) therapy.... 
INFECTIOUS DISEASES | SEROCONVERSION | Clinical relapse | Serum soluble ST2 | HBSAG | INTERLEUKIN-33 | Nucleos(t)ide analogue therapy | IL-33 | DISCONTINUATION | CESSATION | Chronic hepatitis B | Treatment cessation | PREDICTORS | HBV DNA | LIVER-DAMAGE | ANTIGEN
Journal Article
Journal Article
Journal Article
Gut and Liver, ISSN 1976-2283, 2011, Volume 5, Issue 3, p. 278
Although the prevalence of chronic hepatitis B has decreased considerably in recent years due to widespread use of the hepatitis B virus (HBV) vaccine, its... 
Chronic hepatitis B | Nucleos(t)ide analogue | Hepatitis B virus | Drug resistance
Journal Article
Gut and Liver, ISSN 1976-2283, 2011, Volume 5, Issue 3, p. 278
Although the prevalence of chronic hepatitis B has decreased considerably in recent years due to widespread use of the hepatitis B virus (HBV) vaccine, its... 
Chronic hepatitis B | Nucleos(t)ide analogue | Hepatitis B virus | Drug resistance
Journal Article
Gut and Liver, ISSN 1976-2283, 2011, Volume 5, Issue 3, p. 278
Although the prevalence of chronic hepatitis B has decreased considerably in recent years due to widespread use of the hepatitis B virus (HBV) vaccine, its... 
Chronic hepatitis B | Nucleos(t)ide analogue | Hepatitis B virus | Drug resistance
Journal Article
Gut and Liver, ISSN 1976-2283, 2011, Volume 5, Issue 3, p. 278
Although the prevalence of chronic hepatitis B has decreased considerably in recent years due to widespread use of the hepatitis B virus (HBV) vaccine, its... 
Chronic hepatitis B | Nucleos(t)ide analogue | Hepatitis B virus | Drug resistance
Journal Article
Journal of Gastroenterology and Hepatology (Australia), ISSN 0815-9319, 02/2017, Volume 32, Issue 2, pp. 451 - 458
Journal Article
Journal Article